These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17963018)

  • 1. Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?
    Tektonidou MG; Skopouli FN
    Clin Rheumatol; 2008 Apr; 27(4):541-2. PubMed ID: 17963018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature.
    De Leonardis F; Govoni M; Lo Monaco A; Trotta F
    Clin Exp Rheumatol; 2009; 27(3):503-6. PubMed ID: 19604446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visceral leishmaniasis related to infliximab administration].
    Romaní-Costa V; Sánchez C; Moyá F; Estany C
    Enferm Infecc Microbiol Clin; 2004 May; 22(5):310. PubMed ID: 15207130
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous and visceral leishmaniasis during anti-TNFα therapy.
    Guarneri C; Bevelacqua V; Patterson JW; Tchernev G
    Wien Med Wochenschr; 2017 Mar; 167(3-4):78-82. PubMed ID: 27832423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Dereure J; Jorgensen C; Sany J
    Clin Exp Rheumatol; 2005; 23(6):891-2. PubMed ID: 16396712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let off the leash: kala-azar following the use of tumour necrosis factor antibodies.
    Khan A; Coakley G; Cosgrove C; Lockwood D
    BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22789834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate.
    Hadjipetrou A; Anyfantakis D; Gkogkou A; Palla K; Lagoudaki E; Milonaki T; Kastanakis S
    Infez Med; 2014 Sep; 22(3):230-5. PubMed ID: 25269966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab.
    Kritikos K; Haritatos E; Tsigkos S; Gounari P; Skrapari I; Gounaris T; Sioula E
    J Clin Rheumatol; 2010 Jan; 16(1):38-9. PubMed ID: 20051756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
    Hakimi S; Rivière S; Del Giudice P; Dereure J; Le Quellec A
    Dermatology; 2010; 220(1):63-5. PubMed ID: 19907139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
    Antoni C; Manger B
    Z Rheumatol; 2003 Jun; 62(3):235-9. PubMed ID: 12827399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
    Montesu MA; Addis GM; Satta R; Cottoni F
    G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases.
    Erre GL; Mesina P; Tonelli N; Passiu G
    Clin Exp Rheumatol; 2010; 28(4):590-1. PubMed ID: 20659417
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
    Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
    Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature.
    Català A; Roé E; Dalmau J; Pomar V; Muñoz C; Yelamos O; Puig L
    Dermatology; 2015; 230(3):204-7. PubMed ID: 25633623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset tuberculosis infection in patients receiving anti-TNFα therapy.
    Mongey AB; Doran JP; Kleinerova J; Fitzgerald O; McDonnell TJ
    QJM; 2014 Jan; 107(1):69-71. PubMed ID: 23970181
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab for psoriasis and psoriatic arthritis.
    Antoni C; Manger B
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S122-5. PubMed ID: 12463461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic neuritis in a psoriatic arthritis patient treated by infliximab.
    Minami-Hori M; Tsuji H; Takahashi H; Hanada K; Iizuka H
    J Dermatol; 2013 Apr; 40(4):298-9. PubMed ID: 23289758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.